Document Detail

Tetrahydrobiopterin in intestinal lumen: its absorption and secretion in the small intestine and the elimination in the large intestine.
MedLine Citation:
PMID:  19031009     Owner:  NLM     Status:  MEDLINE    
In treating hereditary deficiency of tetrahydrobiopterin (BH(4)), supplementation with BH(4) might be the ultimate choice of therapy. Oral administration of BH(4) has been believed to be inefficient owing to poor absorption of BH(4) in the intestine. In this study, we found a considerable amount of BH(4) as well as its oxidized pterins in the ingredients of intestinal lumen of mice when they were served food that did not contain significant amounts of biopterin. Ligation of the biliary duct led to significant decrease in luminal biopterin. Supplementation of BH(4) either by intraperitoneal administration of sepiapterin or of 6RBH(4) ((6R)-L-erythro-5,6,7,8-tetrahydrobiopterin) increased the BH(4) content in the intestinal lumen with a slight delay after the rise of blood BH(4). In these mice, biopterin appeared in the large intestine, caecum and colon, 2 h after the administration. The appearance of BH(4) in the large intestine was accompanied by a large amount of pterin (2-amino-4-hydroxypteridine). The amounts of biopterin + pterin that appeared in the large intestine after intraperitoneal administration of BH(4) were not greater than those found after oral administration at the same dose. When the mice were treated with a large dose of antibiotics prior to the BH(4) administration, the amount of biopterin increased in the caecum but the amount of pterin decreased greatly. These results suggested that a large proportion of BH(4) administered moved to the large intestine, where most biopterin was decomposed presumably by enteric bacteria. Nonetheless, most of the orally administered biopterin was taken up by the small intestine and the amount of biopterin reaching the large intestine was almost the same as that which appeared after direct injection of 6RBH(4) into the peritoneal cavity.
K Sawabe; Y Saeki; A Ohashi; K Mamada; K O Wakasugi; H Matsuoka; H Hasegawa
Related Documents :
7890759 - Polylysine and cvim sequences of k-rasb dictate specificity of prenylation and confer r...
18498299 - Determination of the efficacy of terbinafine hydrochloride nail solution in the topical...
6999479 - Hypertension screening and treatment with angiotensin inhibitors. saralasin and captopril.
12745049 - Droperidol in the emergency department: is it safe?
3364569 - Thromboxane synthesis inhibitors and postprandial jejunal capillary exchange capacity.
10867059 - Free radicals in licorice-flavored sweets can be detected noninvasively using low frequ...
21310449 - Factors affecting pharmacokinetics of benzimidazole anthelmintics in food-producing ani...
9799949 - Methods for health risk assessment of chemicals: are they relevant for alcohol?
19702609 - Parental awareness and attitudes of food marketing to children: a community attitudes s...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-11-25
Journal Detail:
Title:  Journal of inherited metabolic disease     Volume:  32     ISSN:  1573-2665     ISO Abbreviation:  J. Inherit. Metab. Dis.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-02-04     Completed Date:  2009-05-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910918     Medline TA:  J Inherit Metab Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  79-85     Citation Subset:  IM    
Department of Biosciences, Teikyo University of Science and Technology, Uenohara, Yamanashi, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biopterin / administration & dosage,  analogs & derivatives*,  pharmacokinetics,  secretion
Dose-Response Relationship, Drug
Injections, Intraperitoneal
Intestinal Absorption* / drug effects
Intestine, Large / metabolism
Intestine, Small / metabolism
Intestines / metabolism*
Mice, Inbred C57BL
Mice, Inbred Strains
Time Factors
Reg. No./Substance:
17528-72-2/5,6,7,8-tetrahydrobiopterin; 22150-76-1/Biopterin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Study on the use of drugs in patients with enteral feeding tubes.
Next Document:  A novel missense (A79V) mutation of goat PROP1 gene and its association with production traits.